AI-driven QbD: Advancing predictive, data-driven pharma formulation development using artificial…
Introduction: Moving beyond conventional QbD
Quality by Design (QbD) has become a cornerstone of pharmaceutical development by…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lessons from the Delhi–Agra–Puducherry counterfeit medicine investigation
Introduction
India is often described as the “pharmacy of the world.” Yet, the growing menace of counterfeit and substandard…
Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell…
Immuneel Therapeutics, India's pioneering cell and gene therapy company, announced a strategic partnership with Arogya Finance to…
The fine line between reform and risk
A couple of recent notifications, one a notified amendment and the second one, a proposed amendment, concerning medicines have…
FOPE seeks CDSCO clarification on pharmacovigilance obligations under revised Schedule M
The Federation of Pharma Entrepreneurs (FOPE) has sought clarifications from the Central Drugs Standard Control Organization…
ABB’s Machine Automation division appoints Pratip Samanta as RMD for Southern and Eastern Asia
B&R, ABB’s Machine Automation division, announced the appointment of Pratip Samanta as new Regional Managing Director (RMD)…
Centre amends Drugs Rules, 1945 to ensure uniform regulation of advanced cell and gene therapies
The Central Government has amended the Drugs Rules, 1945 to bring cell or stem cell-derived products, gene therapeutic products…
Shantha Biologics, Novo Nordisk collaborate for cartridge fill-finish services in India
No financial terms or further details of the agreement were disclosed.
From packaging to patient outcomes: Why India’s latest DPCO amendment signals a new direction for…
The pharmaceutical industry has traditionally regarded packaging as the final stage of manufacturing—a necessary component that…
DoP amends DPCO 2013 to ease compliance, clarify overcharging liability
The Department of Pharmaceuticals (DoP) has notified the Drugs (Prices Control) Amendment Order, 2026, introducing a series of…